Oxytocin for frontotemporal dementia: A randomized dose-finding study of safety and tolerability

OBJECTIVE: To determine the safety and tolerability of 3 doses of intranasal oxytocin (Syntocinon; Novartis, Bern, Switzerland) administered to patients with frontotemporal dementia (FTD). METHODS: We conducted a randomized, parallel-group, double-blind, placebo-controlled study using a dose-escalat...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neurology
Egile Nagusiak: Finger, Elizabeth C., MacKinley, Julia, Blair, Mervin, Oliver, Lindsay D., Jesso, Sarah, Tartaglia, Maria C., Borrie, Michael, Wells, Jennie, Dziobek, Isabel, Pasternak, Stephen, Mitchell, Derek G.V., Rankin, Katherine, Kertesz, Andrew, Boxer, Adam
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Lippincott Williams & Wilkins 2015
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4336088/
https://ncbi.nlm.nih.gov/pubmed/25503617
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000001133
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak